Drug Discovery Using Chemoproteomics Platform
7 additional undisclosed programs RD oncology
Frontier Medicines is generating medicines to treat previously undruggable disease-causing targets. Chemoproteomics is an approach to understand the interaction between small molecules and proteins in cellular contexts. Frontier is using their proprietary platform, powered by chemoproteomics along with covalent chemistry and machine learning to accelerate the discovery and development of precision medicines. The platform uses insights from proteome screening in disease relevant systems along with proprietary techniques and algorithms enabling rapid identification and assessment of actionable leads for undruggable targets. Frontier is using their platform to build a pipeline of precision medicines initially focused on oncology.